Introduction {#S0001}
============

Outpatients with chronic diseases such as hypertension, diabetes mellitus, dyslipidemia, and hyperuricemia usually take medications over long periods. Prescriptions for these medications generally do not change as long as the patient's condition is stable and/or adverse events do not occur.

In Japan, almost all outpatients receive their medications on the day they are prescribed because, under the national health insurance program, prescriptions expire in 4 days. Furthermore, the Japanese national health system has not adopted a refill (or a repeat) prescription program, and the number of total days of medication supplies per single prescription is lower than that in other countries. For example, according to a Survey of Medical Care Activities in Public Health Insurance,[@CIT0001] distribution of the number of prescription days for all medications prescribed in 2016 was as follows: ≤14 days, 87.6%; ≥15 days to ≤30 days, 8.7%, and ≥31 days, 3.7%. Prescription days per one single prescription are generally unlimited to the range that a physician in Japan foresees current medical condition lasting, and the proportion of prescriptions written for ≥31 days was very small.

However, outpatients with chronic diseases often take the same medications as those prescribed initially over the long term, so that actual number of days of medication supplies are longer than the prescription days reported in the survey above. Our study aimed to clarify how long they fill prescriptions for the same medications and how many medications they continuously take over 1 year. Based on our findings, we will discuss the possibility that these patients should receive a longer-term medication supply with partial fills by physician's instructions ("Bunkatu Chozai" in Japanese), similar to a basic prescription refill.

Methods {#S0002}
=======

Medication records, including medicines prescribed repeatedly over 1 year, were extracted from an electronic database in a community pharmacy chain (Yakuju Co. Ltd.), consisting of 155 stores in the Japanese Kanto region (eastern half of Japan, including Tokyo). Medication records were collected from April 1, 2016, to March 31, 2017, and were anonymized to protect personal information. Outpatient records that showed total days between initial and final dispensation date ≥330 days and total days of medication ≥180 days for individual medications were included in this analysis. In addition, sex, age, and the date that medications prescribed for patients were filled in community pharmacies (ie, the dispensation date) were collected. The medicines were identified by individual medicine codes of Japan (referred to as YJ codes), brand names, and generic names.

The medication possession ratio (MPR) was used to assess medication fill adherence.[@CIT0002]--[@CIT0008] The MPR was defined as the total days of medication supplies by prescription divided by the observation period that starts at the first dispensation date and ends at the last dispensation date for individual medications, and expressed as a percentage.[@CIT0004] Days' supply beyond the end of the observation period was excluded. When MPR is \>100%, it indicates that there may be overlaps in days between taking medications; this may leave medicines not taken regularly. When MPR is \<100%, it indicates that there may be gaps in the days between taking medications. As has been reported extensively in the literature describing adherence rates for refilled prescriptions, medication refill adherence is considered satisfactory if MPR is ≥80%.[@CIT0005],[@CIT0006] Although MPR cannot ensure that patients are taking their medications, it provides an estimate of the highest possible level of medication consumption over a particular time frame.

Medication records of patients with the same prescription ≥2 times, each for ≥14 days, were collected by individual medications. Among these records, those having an observation period ≥330 days and total days of medication supplies ≥180 days were considered to be taking long-term medications. These records were extracted from the collected record and summed for each patient. Both mean MPR and the proportion of patients taking medications with an MPR ≥80% but \<110% were calculated; these values were compared between males and females, patients ≥65 years and \<65 years, and between those taking ≥5 medications and \<5 medications.

The ethics committee of the Social University (the General Incorporated Association, 8-5-26 Akasaka, Minato-ku, Tokyo, Japan) approved this study (approval day: March 16, 2017; approval number: SU-0005). Informed consent for each outpatient corresponding to the medication record stored in the database was not needed because the medication records analyzed in our study were anonymized in a linkable fashion according to the requirement for protection of personal information.

Statistical analysis {#S0003}
====================

Statistical tests were performed using JMP Pro 14 (SAS, 6-10-1 Roppongi, Minato-ku, Tokyo, Japan). Chi-square test (*P*, 0.001) was used to determine differences in the proportion of patients with an MPR ≥80% but \<110% between males and females, between the two age groups (≥65 years and \<65 years), and between two medication groups (≥5 medications and \<5 medications).

Results {#S0004}
=======

Medication records for the 1-year survey included 787,451 outpatients. Among these patients, 158,938 (20.2%) had medications prescribed more than twice and with each medication prescribed for ≥14 days. Of these patients, 34,549 (4.4% of all patients in the database) received medications for ≥330 total days between initial and final dispensation date and ≥180 total days of medication supplies. Records for these patients were included in this analysis.

The mean age of patients was 66.0±17.4 years, 49.2% of male, and 21,789 (63.1%) were ≥65 years ([Table 1](#T0001){ref-type="table"}).Table 1Characteristics of patients receiving long-term and repeat medications and those taking ≥5 medicines versus \<5 medicinesTotal\
34,549 (100%)\<5 medications\
26,720 (77.3%)≥5 medications\
7,829 (22.7%)Age (SD), years66.0 (17.4)64.6 (17.8)71.0 (15.0) \<65 years12,760 (36.9%)10,638 (39.8%)2,122 (27.1%) ≥65 years21,789 (63.1%)16,082 (60.2%)5,707 (72.9%)Male16,980 (49.2%)12,973 (48.6%)4,007 (51.2%)Prescription days (SD)33.2 (15.6)33.8 (15.9)31.1 (14.4) \<10 days307 (0.9%)238 (0.9%)69 (0.9%) 10--40 days27,279 (79.0%)17,816 (66.7%)6,460 (82.5%) ≥40 days6,963 (20.2%)8,666 (32.4%)1,300 (16.6%)Medications (SD)3.2 (2.3)2.2 (1.1)6.7 (1.9)Total days of medication supplies (SD)320.5 (39.1)317.2 (40.9)332.0 (29.1)Medication possession ratio (MPR) (SD), %93.6 (11.2)92.6 (11.8)96.8 (8.2) \<80%3,936 (11.4%)3,633 (13.6%)303 (3.9%) 80--110%30,142 (87.2%)22,745 (85.1%)7,397 (94.5%) ≥110%471 (1.4%)342 (1.3%)129 (1.6%)

Prescription days and total days of medication supplies {#S0004-S2001}
-------------------------------------------------------

The mean prescription days per single patient was 33.2±15.6 days ([Table 1](#T0001){ref-type="table"}). The mean total days of medication supplies was 320.5±39.1 days within a mean observation period of 342.6±8.1 days. A total of 80.5% received medications for ≥300 days. Thus, outpatients generally received, on average, medications around 10 times with a 33-day supply of the prescription from a community pharmacy per year.

A total of 79.0% of patients had a mean number of prescription days ≥10 days but \<40 days. A total of 20.2% had the prescription days ≥40 days, and only 0.9% had the prescription days \<10 days. The frequency distribution of the mean prescription days ranged from 4.5 to 180 days ([Figure 1](#F0001){ref-type="fig"}).Figure 1Frequency distribution of mean prescription days per one single patient for long-term medications. Minimum value of mean prescription days was 4.5-day (n=1) and maximum value 180-day (n=2).

As can be seen in [Figure 1](#F0001){ref-type="fig"}, the proportion of the prescription days ≥30 days was considerably higher than that reported by a Survey of Medical Care Activities in Public Health Insurance (3.73% for ≥31 days,).[@CIT0001] Around one-half (49.4%) of patients in this study received long-term and repeat medications with the prescription days ≥30 days.

Number of medications {#S0004-S2002}
---------------------

The number of medications prescribed per patient ranged from 1 to 22 for long-term and repeat medications ([Figure 2](#F0002){ref-type="fig"}). The mean number of medications prescribed was 3.2±2.3 ([Table 1](#T0001){ref-type="table"}). More than one-fifth of patients (22.7%) were taking ≥5 medications. There was a significant difference between males and females in those taking ≥5 medications (male, 51.2%; female, 48.8%; *p*\<0.0001).Figure 2Number of long-term medications prescribed per patient.

Among all patients, 7,829 (51.2% male) were taking ≥5 medications and 26,720 patients were taking \<5 medications (48.6% male). In addition, patients taking ≥5 medications were significantly more likely to be elderly (≥65 years vs \<65 years, 72.9% vs 60.2%, respectively; *P*\<0.0001).

Medication possession ratio (MPR) {#S0004-S2003}
---------------------------------

The mean MPR for all patients was 93.6±11.2% ([Table 1](#T0001){ref-type="table"}). A total of 87.2% of patients had an MPR ≥80% but \<110%. A total of 11.4% had an MPR \<80%, and only 1.4% had an MPR ≥110%. The frequency distribution of MPR ranged from 49.5% to 302.7% ([Figure 3](#F0003){ref-type="fig"}).Figure 3Frequency distribution of medication possession ratio (MPR) for long-term medications. Minimum value of MPR was 49.5% (n=1) and maximum value 302.7% (n=1).

Patients taking ≥5 medications were significantly more likely to have an MPR ≥80% but \<110% compared with those taking \<5 medications (94.5% vs 85.1%, respectively; *P*\<0.0001) ([Table 1](#T0001){ref-type="table"}).

Representative medications prescribed for the long term {#S0004-S2004}
-------------------------------------------------------

A total of 881 medications were prescribed repeatedly over 1 year. [Table 2](#T0002){ref-type="table"} shows the top 20 medications along with their anatomical therapeutic chemical (ATC) classification. These 20 medications had a mean MPR ranging from 92.7% to 96.4%, a mean of prescription days per patient ranging from 25.2 to 38.1, and a total days' supply (accumulated from all values except the last prescription day) ranging from 317.4 to 331.3.Table 2Number of days and medication possession ratio (MPR) for top 20 medicines prescribed overallGeneric drug nameATC classification^a^nAverage prescription days per patient (SD)Total days with prescription supplies (SD)MPR (SD), %Amlodipine besylate**C08**5,53733.8 (14.6)326.9 (32.4)95.5 (9.2)Rosuvastatin calcium**C10**2,43634.5 (14.5)322.3 35.0)94.2 (10.0)AspirinB012,25834.9 (16.9)329.4 (29.7)96.1 (8.4)Magnesium oxideA02, A06, A122,17230.3 (15.8)325.1 (42.2)94.6 (12.0)Atorvastatin calcium hydrate**C10**2,04434.3 (14.8)325.9 (31.9)95.2 (9.1)LansoprazoleA021,85233.2 (15.2)328.8 (32.0)96.0 (9.0)EtizolamN051,78427.0 (8.9)331.3 (60.7)96.4 (17.3)Nifedipine**C08**1,65733.9 (14.9)328.6 (32.2)96.0 (9.2)Pitavastatin calcium hydrate**C10**1,58634.4 (14.1)326.3 (31.0)95.3 (8.9)Candesartan cilexetil**C09**1,46435.0 (15.5)327.0 (31.5)95.5 (9.0)Telmisartan**C09**1,44234.4 (14)329.4 (29.2)96.2 (8.2)BrotizolamN051,34525.2 (6.0)324.0 (52.7)94.5 (15.1)Allopurinol**M04**1,32734.7 (16.0)324.4 (33.6)94.8 (9.6)Zolpidem tartrateN051,30525.6 (5.7)317.4 (52.0)92.6 (14.9)Febuxostat**M04**1,25934.8 (15.2)324.4 (33.6)94.8 (9.5)Esomeprazole magnesium hydrateA021,23034.3 (15.5)324.6 (38.5)94.8 (11.1)Sitagliptin phosphate hydrate**A10**1,20536.7(15.5)328.9 (27.3)96.2 (7.7)RebamipideA021,19530.4 (14.3)318.0 (46.0)92.7 (13.3)FamotidineA021,18832.4 (16.3)329.1 (31.4)95.9 (8.9)Metformin hydrochloride**A10**1,10138.1 (15.0)323.7 (33.4)94.7 (9.7)[^1] Table 3Mean medication possession ratio (MPR) for four therapeutic categoriesTherapeutic classificationATC classificationPatients taking medications by therapeutic classificationnAge (SD), yearsMale, %MPR (SD), %nMPR range of 80--110%MPR range of ≥110%Hypertension agentsC02-C0914,824 (42.9%)71.7 (11.8)51.895.9 (8.9)20,396 (92.9%)200 (0.9%)Dyslipidemia agentsC108,838 (25.6%)70.2 (11.4)45.295.1 (9.3)8,507 (91.9%)65 (0.7%)Antidiabetic agentsA104,252 (12.3%)68.5 (11.5)60.195.6 (8.6)6,841 (92.9%)53 (0.8%)Hyperuricemia agentsM042,883 (8.3%)67.8 (13.4)85.194.5 (9.8)2,744 (90.7%)21 (0.7%)[^2]

Amlodipine besylate, an antihypertensive, was prescribed for the highest number of patients. This drug showed a mean MPR of 95.5% ±9.2%, a mean of 33.8±14.6 prescription days per patient, and a mean of 326.9±32.4 total medication days.

Among the 20 medications, eleven medications were included in four therapeutic categories related to chronic diseases shown in [Table 3](#T0003){ref-type="table"}.

MPR of medications based on therapeutic category {#S0004-S2005}
------------------------------------------------

Hypertensive agents were the most commonly prescribed drugs, followed by dyslipidemic agents, antidiabetic agents (limited to oral and non-insulin agents), and hyperuricemia agents ([Table 3](#T0003){ref-type="table"}). The mean MPR for all four agents was ≥90% and the proportion of patients with an MPR range of 80--110% was also ≥90%.

Discussion {#S0005}
==========

Our study found that around 4% of Japanese outpatients generally received 3 medications with a 33-day filling period over 10 pharmacy visits during 1-year survey. The medication fill adherence was, on average, estimated at over 90%. Of these patients, those taking ≥5 medications were significantly more likely to be ≥65 years higher and in the proportion with an MPR ≥80% but \<110% than those taking \<5 medications.

MPR estimates the proportion of times that medications are filled over a particular observation period and the highest possible level of medication consumption.[@CIT0002]--[@CIT0004] Based on the MPR values in our study, patients received medications prescribed by their physicians regularly. These findings are particularly important for patients undergoing long-term medical treatment and indicate that patients are making regular physician visits, as medications are not automatically refilled in Japan.

In a medication refill adherence study using a pharmacy claims database among patients with chronic diseases in the United State,[@CIT0007] MPR ≥80% was detected for 72.3% of patients with hypertension and 65.4% with type 2 diabetes mellitus.

In our study, the MPR was ≥90% for the topmost frequently prescribed medications, which is higher than that shown in the previous study. An adherence study of patients with chronic diseases receiving Medicaid in the United States found a mean MPR for a 30-day refill of medications of 71% in patients with hypertension and 69% for patients with type 2 diabetes mellitus, and a mean MPR for a 90-day refill of 83% and 80%, respectively.[@CIT0008] The 33-day refill period in our study is similar to the 30-day period in the Medicaid study, although MPR findings were higher in our study.

The one way that prescriptions in Japan can be filled partially ("Bunkatu Chozai" in Japanese) is when it is difficult to preserve the medication for a long period; in these cases, medications are partially filled and the remaining portion is filled at a later time. Another way for partial filling of prescriptions is according to the physicians' indications, which is similar to refilling prescriptions based on a specified number of refills before a certain expiration date. Thus, patients can obtain more of the same medications from pharmacists without seeing the prescribers within a total of the prescription days and 4 days of the prescription expiration date.[@CIT0009] This novel prescription format introduced in 2018 allows physicians to prescribe a partial days' supply, and the number of partial fills of prescriptions in the remarks column of prescription sheets.

The process for partial filling of a prescription in Japan differs substantially from that in the United States, where partial filling of a prescription is permitted when the pharmacist is unable to supply the prescribed amount or the prescriber requests less than the full quantity called for in a prescription.

Our study indicated that outpatients who repeatedly received the same medications as prescribed initially and who had a medication supply ≥180 days during this 1-year survey showed high adherence to both visiting their physicians to obtain a prescription. It is reasonable to assume that outpatients should be able to receive a long-term supply of medication (eg, 90 days), with an order for partial filling on the part of the physician, and without the need for a new prescription for each refill.

When this partial filling of prescriptions is expanded and extended, community pharmacists should regularly consult with patients about taking their medications as prescribed, not only to help them understand the need to continue treatment, but also to enhance their medication adherence. These consultations may also help to reduce polypharmacy, which is common in people aged ≥65 years. These elderly patients may have a greater risk for polypharmacy, that is, inappropriate use of multiple drugs, and should be considered in efforts to reduce unnecessary polypharmacy.[@CIT0010]

Limitations {#S0006}
===========

First, our study used MPR to estimate medication fill adherence. Although systematic reviews have shown that MPR is a reliable measure of adherence,[@CIT0002] our study cannot report actual adherence to taking medications. However, we can discuss continuity and regularity of Japanese outpatients in terms of behavior regarding receiving their medicines from a community pharmacy. Regular receipt of medications may mean that medications are being used. However, this could not be proven in our study.

Second, there are pharmacies within community pharmacy chains and individual pharmacies in Japan. Our study was based on medication records stored in a community pharmacy chain. This chain is controlled by a management headquarters, which may influence which medications are used. However, as medications are filled as prescribed by physicians in terms of both brand and generic medicines, the headquarters does not control the medication used except when a generic medicine is prescribed by the physician. Thus, all branches within Yakuju are similar to individual pharmacies, limiting the possibility for differences between these pharmacies.

Conclusion {#S0007}
==========

Our study found that Japanese outpatients who repeatedly received the same medications as prescribed initially and who had a medication supply ≥180 days over 1 year were around 4% of all and showed high medication fill adherence over 90%. It is reasonably assumed that these patients could receive a longer-term medication supply with the novel partial fills based on a physician's instruction ("Bunkatu Chozai" in Japanese). This prescription format introduced in 2018 would be similar to a basic prescription refill and allows physicians to prescribe a partial days' supply, and the number of partial fills of prescriptions.
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[^1]: **Note:** ^a^ACT classification of being bold indicates that these medications are included in four therapeutic categories related to chronic diseases shown in [Table 3](#T0003){ref-type="table"}.

    **Abbreviation:** ATC, anatomical therapeutic chemical.

[^2]: **Abbreviation:**ATC, anatomical therapeutic chemical.
